Member Info for volcano

GCG20
Gold (Feb '20)
1,532.4
+9.3

GCJ20
Gold (Apr '20)
1,538.5
+9.2
GCM20
Gold (Jun '20)
1,544.6
+9.5

197.00 GBX +11.00 (5.91%)
30 Dec, 09:04 GMT · Disclaimer

If you haven’t heard of S4, you will certainly be familiar with its founder and chief executive – former WPP boss Sir Martin Sorrell.

With a ‘buy-and-build’ strategy, Sorrell turned WPP from an advertising minnow into a FTSE 100 giant over 30 years.

He has already built S4 into an £850million-valued firm, and I expect 2020 to bring more deals.

Drugmakers AstraZeneca and Merck & Co reported that Lynparza has been approved in the US for the maintenance treatment of adult patients with deleterious or suspected pancreatic cancer.

The approval follows the recommendation from the US FDA Oncologic Drugs Advisory Committee for Lynparza, which was based on results from the pivotal phase III POLO trial. It showed an improvement in progression-free survival, where Lynparza nearly doubled the time patients with pancreatic cancer lived without disease progression or death.

"Patients with advanced pancreatic cancer historically have faced poor outcomes due to the aggressive nature of the disease and limited treatment advances over the last few decades. Lynparza is now the only approved targeted medicine in biomarker-selected patients with advanced pancreatic cancer," said Dave Fredrickson, executive vice president of Oncology division at AstraZeneca.

is on the up

Gold (Feb '20)
1,516.9
+2.5

Gold prices are on the up

Gold (Feb '20)
1,516.9
+2.5

Resistance Point 100.443

is getting harder to trade now ,

95.00 GBX +7.00 (7.95%)
27 Dec, 08:30 GMT · Disclaime

Resistance Point 91.197

Average volume 159.84k
Shares outstanding 46.90m
Free float 28.33m

yes, looking good today .
63.45 GBX +1.25 (2.01%)
24 Dec, 09:05 GMT · Disclaimer

another very good day , soon will be a £1 .
88.94 GBX +7.44 (9.13%)
24 Dec, 08:47 GMT · Disclaimer

84.90 GBX +3.40 (4.17%)
24 Dec, 08:12 GMT · Disclaimer

81.76 GBX +11.26 (15.97%)
23 Dec, 10:40 GMT · Disclaimer

78.00 GBX +7.50 (10.64%)
23 Dec, 09:04 GMT · Disclaimer

NMC Health PLC Add to myFT
NMC held talks to raise €200m in off-balance sheet debt to fund growth

Short interest builds against NMC Health
Muddy Waters isn’t the only financial institution to take a short position against NMC Health.

AQR Capital Management has a 2.69% position against the stock, alongside PSquared Asset Management (1.10%), Portsea Asset Management (0.71%) and Gladstone Capital Management (0.51%), according to the Financial Conduct Authority’s daily short position report.

14.00 GBX +1.50 (12.00%)
20 Dec, 08:19 GMT · Disclaimer

there is good news and more to come.
28.85 GBX +1.70 (6.25%)
20 Dec, 08:03 GMT · Disclaimer

i would say so from 80p few weeks ago now is 123p, nice